Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy

Bashair M Mussa,1 Ankita Srivastava,2 Abeer Al-Habshi,2 Abdul Khader Mohammed,2 Rabih Halwani,2,3 Salah Abusnana3,4 1Basic Medical Science Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 2Sharjah Institute for Medical Research, University of Sharjah, Sharjah, U...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mussa BM, Srivastava A, Al-Habshi A, Mohammed AK, Halwani R, Abusnana S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	mcp-1 diabetic neuropathy type 2 diabetes mellitus inflammatory biomarkers emirati population Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/5bb0af03a99440b3863c559ef96eddf5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5bb0af03a99440b3863c559ef96eddf5
record_format	dspace
spelling	oai:doaj.org-article:5bb0af03a99440b3863c559ef96eddf52021-12-02T18:07:04ZInflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy1178-7007https://doaj.org/article/5bb0af03a99440b3863c559ef96eddf52021-07-01T00:00:00Zhttps://www.dovepress.com/inflammatory-biomarkers-levels-in-t2dm-emirati-patients-with-diabetic--peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Bashair M Mussa,1 Ankita Srivastava,2 Abeer Al-Habshi,2 Abdul Khader Mohammed,2 Rabih Halwani,2,3 Salah Abusnana3,4 1Basic Medical Science Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 2Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates; 3Clinical Science Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 4Diabetes and Endocrinology Department, University Hospital Sharjah, Sharjah, United Arab EmiratesCorrespondence: Bashair M MussaBasic Medical Science Department, College of Medicine, University of Sharjah, P.O. Box: 27272, Sharjah, United Arab EmiratesTel +971-65057220Fax +971-6558579Email bmussa@sharjah.ac.aeIntroduction: Previous studies have suggested the involvement of chronic low‐grade inflammation in the pathogenesis of diabetic neuropathy (DNP). However, none of these studies have examined the levels of monocyte chemoattractant protein-1 (MCP-1) in type 2 diabetes mellitus (T2DM) patients with confirmed diagnosis of neuropathy. Therefore, the present study aims to investigate the levels of MCP-1 along with IL-6, IL-8 and TGF-β in patients with T2DM and confirmed neuropathy and identify correlations, if any, between MCP-1 and other parameters.Methods: A single center cross-sectional clinical study was conducted at University Hospital Sharjah (UHS) and University of Sharjah. One hundred and two patients with T2DM were recruited from diabetes clinics at UHS and were stratified into different groups based on diagnosis of DNP and other parameters. Several analyses were conducted to evaluate and compare the levels of MCP-1, IL-6, IL-8, and TGF-β across these groups of patients and identify correlations, if any, between MCP-1 and other variables.Results: A significant increase was found in the levels of MCP-1 in T2DM patients with DNP compared to the patients without DNP (p=0.002, p-adj=0.007). Further analysis has shown that levels of IL-8 (p=0.008) and TGF-β (p=0.06) were increased and decreased, respectively, in patients with DNP compared to patients without DNP. Moreover, strong correlations were found between MCP-1, IL-8 and TGF-β levels.Conclusion: The key finding of the present study is the significant elevation in levels of MCP-1 in T2DM patients with DNP compared to the patients without DNP and IL-8 and TGF-β were strong predictors of MCP-1 increased levels.Keywords: MCP-1, diabetic neuropathy, type 2 diabetes mellitus, inflammatory biomarkers, Emirati populationMussa BMSrivastava AAl-Habshi AMohammed AKHalwani RAbusnana SDove Medical Pressarticlemcp-1diabetic neuropathytype 2 diabetes mellitusinflammatory biomarkersemirati populationSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 3389-3397 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	mcp-1 diabetic neuropathy type 2 diabetes mellitus inflammatory biomarkers emirati population Specialties of internal medicine RC581-951
spellingShingle	mcp-1 diabetic neuropathy type 2 diabetes mellitus inflammatory biomarkers emirati population Specialties of internal medicine RC581-951 Mussa BM Srivastava A Al-Habshi A Mohammed AK Halwani R Abusnana S Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
description	Bashair M Mussa,1 Ankita Srivastava,2 Abeer Al-Habshi,2 Abdul Khader Mohammed,2 Rabih Halwani,2,3 Salah Abusnana3,4 1Basic Medical Science Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 2Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates; 3Clinical Science Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 4Diabetes and Endocrinology Department, University Hospital Sharjah, Sharjah, United Arab EmiratesCorrespondence: Bashair M MussaBasic Medical Science Department, College of Medicine, University of Sharjah, P.O. Box: 27272, Sharjah, United Arab EmiratesTel +971-65057220Fax +971-6558579Email bmussa@sharjah.ac.aeIntroduction: Previous studies have suggested the involvement of chronic low‐grade inflammation in the pathogenesis of diabetic neuropathy (DNP). However, none of these studies have examined the levels of monocyte chemoattractant protein-1 (MCP-1) in type 2 diabetes mellitus (T2DM) patients with confirmed diagnosis of neuropathy. Therefore, the present study aims to investigate the levels of MCP-1 along with IL-6, IL-8 and TGF-β in patients with T2DM and confirmed neuropathy and identify correlations, if any, between MCP-1 and other parameters.Methods: A single center cross-sectional clinical study was conducted at University Hospital Sharjah (UHS) and University of Sharjah. One hundred and two patients with T2DM were recruited from diabetes clinics at UHS and were stratified into different groups based on diagnosis of DNP and other parameters. Several analyses were conducted to evaluate and compare the levels of MCP-1, IL-6, IL-8, and TGF-β across these groups of patients and identify correlations, if any, between MCP-1 and other variables.Results: A significant increase was found in the levels of MCP-1 in T2DM patients with DNP compared to the patients without DNP (p=0.002, p-adj=0.007). Further analysis has shown that levels of IL-8 (p=0.008) and TGF-β (p=0.06) were increased and decreased, respectively, in patients with DNP compared to patients without DNP. Moreover, strong correlations were found between MCP-1, IL-8 and TGF-β levels.Conclusion: The key finding of the present study is the significant elevation in levels of MCP-1 in T2DM patients with DNP compared to the patients without DNP and IL-8 and TGF-β were strong predictors of MCP-1 increased levels.Keywords: MCP-1, diabetic neuropathy, type 2 diabetes mellitus, inflammatory biomarkers, Emirati population
format	article
author	Mussa BM Srivastava A Al-Habshi A Mohammed AK Halwani R Abusnana S
author_facet	Mussa BM Srivastava A Al-Habshi A Mohammed AK Halwani R Abusnana S
author_sort	Mussa BM
title	Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
title_short	Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
title_full	Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
title_fullStr	Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
title_full_unstemmed	Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
title_sort	inflammatory biomarkers levels in t2dm emirati patients with diabetic neuropathy
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/5bb0af03a99440b3863c559ef96eddf5
work_keys_str_mv	AT mussabm inflammatorybiomarkerslevelsint2dmemiratipatientswithdiabeticneuropathy AT srivastavaa inflammatorybiomarkerslevelsint2dmemiratipatientswithdiabeticneuropathy AT alhabshia inflammatorybiomarkerslevelsint2dmemiratipatientswithdiabeticneuropathy AT mohammedak inflammatorybiomarkerslevelsint2dmemiratipatientswithdiabeticneuropathy AT halwanir inflammatorybiomarkerslevelsint2dmemiratipatientswithdiabeticneuropathy AT abusnanas inflammatorybiomarkerslevelsint2dmemiratipatientswithdiabeticneuropathy
_version_	1718378630009061376

Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy

Ejemplares similares